Skip to content

A multicenter randomized controlled trial of two kinds of minimally invasive glaucoma surgery for primary open-angle glaucoma

A multicenter randomized controlled trial of two kinds of minimally invasive glaucoma surgery for primary open-angle glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100458
Enrollment
Unknown
Registered
2025-04-09
Start date
2023-10-11
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glacoma

Interventions

3T:3T surgery
GATT:GATT surgery

Sponsors

Beijing Tongren Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Patients with POAG diagnosis. 2) Patients without any anti glaucoma surgery. 3) The age is between 30-75 years old. 4) Anti glaucoma drugs have been used, but the patient cannot continue to use anti glaucoma drugs for personal reasons.It is hoped that the dosage of IOP lowering drugs can be reduced. 5) Patients who have used a variety of anti glaucoma drugs and still have poor control of intraocular pressure. 6) Voluntarily accept the corresponding surgical treatment, and can understand and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Glaucoma patients who have undergone anti glaucoma surgery. 2) Angle closure glaucoma and secondary open-angle glaucoma (including but not limited to: neovascularization.Secondary glaucoma, traumatic glaucoma, etc.). 3) Patients with corneal opacity and unable to clearly view the angle structure. 4) The patient's own condition is not suitable for anti glaucoma surgery under general anesthesia, for example, anti glaucoma surgery cannot be stopped Coagulation drugs, retinal degeneration area or hole without treatment. 5) Patients who cannot cooperate with intraocular pressure measurement due to eye conditions, such as strabismus with large angle,Corneal edema, corneal scar, etc. 6) Other diseases that may affect the assessment of intraocular pressure except glaucoma: intraocular or orbital tumors Iris neovascularization, etc. 7) Patients whose general conditions cannot tolerate surgery. 8) Patients who cannot sign the informed consent for various reasons.

Design outcomes

Primary

MeasureTime frame
intraocular pressure;Glaucoma drugs;complete success;Surgical complications;Condition success;

Secondary

MeasureTime frame
Surgical success rate;

Countries

China

Contacts

Public ContactWang Ningli

Beijing Tongren Hospital Affiliated to Capital Medical University

wningli@vip.163.com+86 135 1102 6669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026